carbonic acid allyl ester-vinyl ester | 119448-08-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机碳酸及其衍生物
• 英文名称: carbonic acid allyl ester-vinyl ester
• 英文别名: Vinyl-allyl-carbonat；Kohlensaeure-allylester-vinylester；Ethenyl prop-2-enyl carbonate
• CAS: 119448-08-7
• 化学式: C₆H₈O₃
• 分子量: 128.128
• InChiKey: ZQHWNCCQPKAZAH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  9
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  氯甲酸乙烯酯 、 烯丙醇 在 吡啶 作用下， 生成 carbonic acid allyl ester-vinyl ester
  参考文献：
  名称：

  Unsaturated carbonate esters

  摘要：

  公开号：

  US02370589A1

文献信息

• [EN] ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS D'ARGININE MÉTHYLTRANSFÉRASE ET LEURS UTILISATIONS
  申请人：EPIZYME INC

  公开号：WO2016044626A1

  公开（公告）日：2016-03-24

  Described herein are compounds of Formula (S-I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds described herein are useful for inhibiting arginine methyltransferase activity. Methods of using the compounds for treating arginine methyltransferase-mediated disorders are also described.

  本文描述了式（S-I）的化合物，其药用盐以及药物组合物。本文描述的化合物对抑制精氨酸甲基转移酶活性有用。还描述了利用这些化合物治疗精氨酸甲基转移酶介导的疾病的方法。
• RAPAMYCIN CARBONATE ESTERS
  申请人：Rhodes Alan

  公开号：US20090253733A1

  公开（公告）日：2009-10-08

  Certain embodiments include carbonate esters of rapamycin at position 42 that are synthesized by a lipase catalyzed regio-specific process. These compounds or a pharmaceutically acceptable salt thereof are useful in the treatment of organ and tissue transplant rejection, autoimmune disease, proliferative disorder, restenosis, cancer, or microbial infection.

  某些实施例包括通过脂肪酶催化的区域特异性过程合成的罗法昔明在第42位的碳酸酯。这些化合物或其药用可接受的盐在器官和组织移植排斥、自身免疫疾病、增殖性疾病、再狭窄、癌症或微生物感染的治疗中是有用的。
• [EN] POLYAMINE-FATTY ACID DERIVED LIPIDOIDS AND USES THEREOF<br/>[FR] LIPIDOÏDES DÉRIVÉS DE POLYAMINE-ACIDE GRAS ET LEURS UTILISATIONS
  申请人：MASSACHUSETTS INST TECHNOLOGY

  公开号：WO2016004202A1

  公开（公告）日：2016-01-07

  The present disclosure provides polyamine-fatty acid derived lipidoids (e.g., compounds of Formula (I) or (II)) and methods of preparing the lipidoids. A described lipidoid includes R-C(=0)-0- moieties (where R is a lipid moiety), which may be hydrolyzed into non-toxic fatty acids. Also provided are compositions including a described lipidoid and an agent (e.g., polynucleotide, small molecule, peptide, or protein). The present disclosure also provides methods, kits, and uses that involve the lipidoids or compositions for delivering an agent to a subject, tissue, or cell and/or for treating and/or preventing a range of diseases, such as genetic diseases, proliferative diseases, hematological diseases, neurological diseases, immunological diseases, gastrointestinal diseases, respiratory diseases, painful conditions, psychiatric disorders, and metabolic disorders.

  本公开提供了聚胺脂肪酸衍生的脂质体（例如，化合物的化学式（I）或（II））以及制备脂质体的方法。所述脂质体包括R-C(=0)-0-基团（其中R是脂质基团），可以水解为无毒脂肪酸。还提供了包括所述脂质体和药剂（例如，多核苷酸、小分子、肽或蛋白质）的组合物。本公开还提供了涉及脂质体或组合物用于将药剂传递给受体、组织或细胞和/或用于治疗和/或预防一系列疾病的方法、试剂盒和用途，例如遗传疾病、增殖性疾病、血液疾病、神经系统疾病、免疫系统疾病、胃肠道疾病、呼吸系统疾病、疼痛症状、精神障碍和代谢性疾病。
• [EN] BLOCK CO-POLY(METAL ORGANIC NANOSTRUCTURES) (BCPMONs) AND USES THEREOF<br/>[FR] CO-POLY(NANOSTRUCTURES ORGANOMÉTALLIQUES) SÉQUENCÉES (BCPMON) ET LEURS UTILISATIONS
  申请人：MASSACHUSETTS INST TECHNOLOGY

  公开号：WO2018022944A1

  公开（公告）日：2018-02-01

  The present disclosure provides (block co-polymer)-(metal organic framework) conjugates (BCPMOFs), such as (block co-polymer)-(metal organic nanostructure) conjugates (BCPMONs), and thermoplastic elastomers, gels, and compositions thereof. Exemplary BCPMONs include (block co-polymer)-(metal organic cage) conjugates (BCPMOCs), (block co-polymer)-(metal organic paddlewheel) conjugates, and (block co-polymer)-(metal organic square) conjugates, such as BCPMONs of Formula (A), (B), or (C). Also described herein are macromonomers for preparing the BCPMONs; thermoplastic elastomers, gels, and compositions involving the BCPMONs; methods of preparing the BCPMONs, thermoplastic elastomers, gels, and compositions; and methods of using the BCPMONs, thermoplastic elastomers, gels, and compositions.

  本公开提供（嵌段共聚物）-（金属有机框架）共轭物（BCPMOFs），例如（嵌段共聚物）-（金属有机纳米结构）共轭物（BCPMONs），以及热塑性弹性体、凝胶和它们的组合物。示例BCPMONs包括（嵌段共聚物）-（金属有机笼）共轭物（BCPMOCs），（嵌段共聚物）-（金属有机风车）共轭物和（嵌段共聚物）-（金属有机方形）共轭物，例如公式（A）、（B）或（C）的BCPMONs。还描述了用于制备BCPMONs的大单体；涉及BCPMONs的热塑性弹性体、凝胶和组合物；制备BCPMONs、热塑性弹性体、凝胶和组合物的方法；以及使用BCPMONs、热塑性弹性体、凝胶和组合物的方法。
• SUPRAMETALLOGELS AND USES THEREOF
  申请人：Massachusetts Institute of Technology

  公开号：US20150225438A1

  公开（公告）日：2015-08-13

  The disclosure provides nanostructures (e.g., nanospheres and nano-paddlewheels) formed through transition metal-ligand (e.g., Pd(II)-, Ni(II)-, or Fe(II)-ligand of Formula (A)) coordination and junction self-assembly. The disclosure also provides supramolecular complexes that include the nanostructures connected by divalent linkers Y. The provided supramolecular complexes are able to form gels (e.g., hydrogels). The gels are suprametallogels and exhibited excellent mechanical properties without sacrificing self-healing and showed high robustness and storage modulus. The present disclosure further provides compositions (e.g., gels) that include the nanostructures or supramolecular complexes and optionally an agent (e.g., small molecule), where the nanostructures and the nanostructure moieties of the supramolecular complexes may encapsulate and slowly release the agent. The nanostructures, supramolecular complex, and compositions may be useful in delivering an agent to a subject, tissue, or cell, as super-absorbent materials, and in treating a disease (e.g., a genetic diseases, proliferative disease (e.g., cancer or benign neoplasm), hematological disease, neurological disease, gastrointestinal disease (e.g., liver disease), spleen disease, respiratory disease (e.g., lung disease), painful condition, genitourinary disease, musculoskeletal condition, infectious disease, inflammatory disease, autoimmune disease, psychiatric disorder, or metabolic disorder).

  该披露提供了通过过渡金属配体（例如Pd(II)-、Ni(II)-或Fe(II)-配体的A式）协调和连接自组装形成的纳米结构（例如纳米球和纳米桨轮）。该披露还提供了由二价连接剂Y连接的纳米结构的超分子复合物。提供的超分子复合物能够形成凝胶（例如水凝胶）。这些凝胶是超金属凝胶，具有出色的机械性能，不会牺牲自愈能力，并展现出高韧性和储存模量。本披露还提供了包括纳米结构或超分子复合物以及可选药剂（例如小分子）的组合物（例如凝胶），其中纳米结构和超分子复合物的纳米结构部分可以包裹并缓慢释放药剂。这些纳米结构、超分子复合物和组合物可用于将药剂输送至受体、组织或细胞，作为超吸水材料，并用于治疗疾病（例如遗传疾病、增生性疾病（例如癌症或良性肿瘤）、血液疾病、神经系统疾病、胃肠疾病（例如肝病）、脾脏疾病、呼吸系统疾病（例如肺部疾病）、疼痛症状、泌尿生殖系统疾病、肌肉骨骼状况、传染病、炎症性疾病、自身免疫疾病、精神障碍或代谢性疾病）。